Axios on MSN
Pittsburgh eyes biotech boom opportunity
A robot at work inside CMU's Biological and Chemical Innovation Cloud Lab. GIF: Ryan Deto/Axios Pittsburgh's biotech industry is ahead of the curve, according to the National Security Commission on ...
Four drug companies — Agomab Therapeutics, Eikon Therapeutics, Spyglass Pharma, and Veradermics — went public this week, ...
Celebrate International Day of Women and Girls in Science 2026 by discovering some of the most influential women shaping biotech today.
Over the past two calendar years, acquirers have agreed to pay more than $38 billion to purchase venture-backed companies in ...
Whisper it, but we may finally be seeing the IPO window reopening in 2026. | Whisper it, but we may finally be seeing the IPO window reopening in 2026.
Led by Brett Giroir and GSK’s ex-chief medical officer, Altesa is advancing a medicine that’s changed hands multiple times and once failed a study in asthma.
A new company founded by a group of biotech veterans, including Bob Langer, came out of stealth mode Tuesday with plans to create pills for everything from obesity to rare diseases. The company, ...
For most students, science is limited to the lab bench — pipetting solutions and taking precise measurements to check the ...
As Demy-Colton and EBD Group’s Biotech Showcase™ concluded its 18th year SAN FRANCISCO, CA, UNITED STATES, February 10, ...
Dallas Entrepreneur Launches $1,000 Andrew Hillman Biotech Grant for Undergraduates DALLAS, TX, UNITED STATES, February ...
Investors' deep pessimism is actually bullish, and less regulatory constraint could fuel new drug approval and M&A Biotech is one of the U.S. stock market's most unloved sectors. But several ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results